Managing the complexities of lower limb wounds - Mepilex® Up

In November 2024, a National Advisory Board Meeting took place in Harrogate, UK. The meeting was attended by nine clinicians specialising in tissue viability, vascular and lower limb wound management.

This was the first of three meetings focused on identifying unmet needs in the management of complex lower limb wounds, particularly highly exuding lower leg wounds and diabetic foot ulcers, which pose significant challenges for patients, clinicians, and healthcare systems. These concepts were refined in subsequent meetings and case studies presented.

Participating clinicians: Leanne Atkin, Tracy Conroy, Chloe Cox, Jacqueline Dark, Luxmi Dhoonmoon, Jane Parker, Hollie Robinson, Jane Todhunter, Kim Whitlock

Mepilex^® Up, a highly absorbent and highly conformable foam dressing, was introduced as a versatile solution for managing the care of of complex lower limb wounds. The advisory board committed to assessing its effectiveness in their clinical settings, aiming to share their findings and refine strategies to overcome challenges in implementing evidence-based treatments for patients with complex lower limb wounds.

This publication aims to highlight the unique abilities of Mepilex^® Up in meeting the challenges associated with lower limb wounds, offering practical solutions grounded in evidence-based advancements in wound dressing technologies.

These innovations support UK clinicians in delivering standardised care aligned with global and national guidelines (National Wound Care Strategy Programme [NWCSP], 2023; International Working Group on the Diabetic Foot [IWGDF], 2023).

Additionally, through case studies, this publication demonstrates how Mepilex^® Up supports timely intervention, effective exudate management, consistent wound coverage, optimised compression therapy, and an enhanced quality of life (QoL) for patients.

These meetings and report were supported by Mölnlycke Health Care.